Viewing Study NCT03564158


Ignite Creation Date: 2025-12-25 @ 12:22 AM
Ignite Modification Date: 2026-01-03 @ 9:15 AM
Study NCT ID: NCT03564158
Status: COMPLETED
Last Update Posted: 2019-01-10
First Post: 2018-04-30
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluate Effects of Meropenem-Vaborbactam on QT/QTc in Healthy Volunteers
Sponsor: Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Healthy View
Keywords: